111 related articles for article (PubMed ID: 3525270)
1. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
Lecavalier L; Hamet P; Chiasson JL
Diabete Metab; 1986 Jun; 12(3):156-61. PubMed ID: 3525270
[TBL] [Abstract][Full Text] [Related]
2. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
3. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
Juntti-Berggren L; Pigon J; Hellström P; Holst JJ; Efendic S
Diabetes Nutr Metab; 2000 Feb; 13(1):7-12. PubMed ID: 10824717
[TBL] [Abstract][Full Text] [Related]
4. Modification in sucrose tolerance test with acarbose, guargum and their combination in patients with non-insulin dependent diabetes.
Shah PK; Lakhotia M; Purohit A; Jain SK; Gupta SK; Bhandari P
J Assoc Physicians India; 1993 Nov; 41(11):703-5. PubMed ID: 8005921
[TBL] [Abstract][Full Text] [Related]
5. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
Madar Z; Melamed EC; Zimlichman R
Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
[TBL] [Abstract][Full Text] [Related]
6. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
7. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
Koch HH; Wudy A; Eberlein G; Quast C
Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
[TBL] [Abstract][Full Text] [Related]
8. Effects of the alpha-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs.
Robertson J; Nelson R; Kass P; Neal L
Am J Vet Res; 1999 May; 60(5):541-5. PubMed ID: 10328421
[TBL] [Abstract][Full Text] [Related]
9. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
10. [Acarbose, an unduly neglected antidiabetic drug].
Iványi J; Gyimesi A
Orv Hetil; 1996 Dec; 137(49):2737-41. PubMed ID: 9679608
[TBL] [Abstract][Full Text] [Related]
11. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
Domke A; Willms B
Med Klin (Munich); 1994 Apr; 89(4):187-92. PubMed ID: 8015532
[TBL] [Abstract][Full Text] [Related]
13. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
[TBL] [Abstract][Full Text] [Related]
15. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
16. Controlled portions of presweetened cereals present no glycemic penalty in persons with insulin-dependent diabetes mellitus.
Wheeler ML; Fineberg SE; Gibson R; Fineberg N
J Am Diet Assoc; 1996 May; 96(5):458-63. PubMed ID: 8621870
[TBL] [Abstract][Full Text] [Related]
17. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
Chiasson JL
Diabet Med; 1996; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
[TBL] [Abstract][Full Text] [Related]
18. Effect of acarbose and simultaneous antacid therapy on blood glucose.
Höpfner M; Durani B; Spengler M; Fölsch UR
Arzneimittelforschung; 1997 Oct; 47(10):1108-11. PubMed ID: 9368703
[TBL] [Abstract][Full Text] [Related]
19. [Acarbose in therapy of diabetes].
Mehnert H
Internist (Berl); 1995 Dec; 36(12):1190-5. PubMed ID: 8567226
[No Abstract] [Full Text] [Related]
20. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
Hayakawa T; Noda A; Kondo T; Okumura N
Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
